National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

A Review of the Economic Evaluation of Prolonged Release Melatonin (Circadin®) For The Short-Term Treatment of Primary Insomnia.

Pharmacoeconomic Evaluation

Commenced Completed Outcome
 August 2008 October 2008 Reimbursement not recommended.

We believe that there is currently insufficient evidence to support the reimbursement of this product under the Community Drugs Schemes.

Melatonin (Circadin) summary